COVID-19 IgG-related autoimmune inflammatory necrotizing myositis
| Autor: | Sai Koyoda, Bibi Ayesha, Maedeh Veyseh |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
myalgia
Coronavirus disease 2019 (COVID-19) Case Report Antibodies Viral Rhabdomyolysis Virus neurology (drugs and medicines) Autoimmune Diseases Diagnosis Differential Necrosis 03 medical and health sciences 0302 clinical medicine Lower respiratory tract infection Pandemic Humans Medicine infections 030212 general & internal medicine Muscle Weakness Muscle biopsy Myositis medicine.diagnostic_test business.industry musculoskeletal and joint disorders COVID-19 Myalgia General Medicine Middle Aged medicine.disease muscle disease Immunoglobulin G Immunology Prednisone Female medicine.symptom Differential diagnosis business 030217 neurology & neurosurgery |
| Zdroj: | BMJ Case Reports |
| ISSN: | 1757-790X |
| DOI: | 10.1136/bcr-2020-239457 |
| Popis: | The COVID-19 pandemic caused by the SARS-CoV-2 virus has affected millions of people around the globe. The most common presentation of COVID-19 is fever and upper and lower respiratory tract infection. Myalgia is fairly common in the prodromal phase of the viral illness which self-resolves. There is very scant literature on autoimmune myositis triggered by COVID-19 infection. We report a case of SARS-CoV-2 infection, who presented with progressive muscle weakness with rhabdomyolysis and necrotizing autoimmune myopathy on muscle biopsy. This case report imposes awareness of musculoskeletal autoimmune processes triggered by COVID-19 which requires clinical suspicion for early diagnosis and initiation of treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|